Bausch Health Companies Inc
$ 5.37
2.09%
05 Jun - close price
- Market Cap 1,964,482,000 USD
- Current Price $ 5.37
- High / Low $ 5.38 / 5.16
- Stock P/E N/A
- Book Value -5.51
- EPS -3.24
- Next Earning Report 2026-07-29
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.06 %
- ROE 0.44 %
- 52 Week High 8.69
- 52 Week Low 4.76
About
Bausch Health Companies Inc. develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology and dermatology. The company is headquartered in Laval, Canada.
Analyst Target Price
$7.50
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-04-29 | 2026-02-18 | 2025-10-29 | 2025-07-30 | 2025-04-30 | 2025-02-19 | 2024-10-30 | 2024-08-01 | 2024-05-02 | 2024-02-22 | 2023-11-02 | 2023-08-03 |
| Reported EPS | 0.78 | 1.1009 | 1.16 | 0.4 | 0.61 | 1.16 | 1.13 | 0.98 | 0.59 | 1.15 | 1.03 | 0.81 |
| Estimated EPS | 0.69 | 1.21 | 1.06 | 0.05 | 0.85 | 1.1267 | 1.02 | 0.88 | 0.72 | 1.02 | 0.92 | 0.73 |
| Surprise | 0.09 | -0.1091 | 0.1 | 0.35 | -0.24 | 0.0333 | 0.11 | 0.1 | -0.13 | 0.13 | 0.11 | 0.08 |
| Surprise Percentage | 13.0435% | -9.0165% | 9.434% | 700% | -28.2353% | 2.9555% | 10.7843% | 11.3636% | -18.0556% | 12.7451% | 11.9565% | 10.9589% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-07-29 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 0.96 |
| Currency | USD |
Previous Dividend Records
| Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | None | None | None | None | None | None | None | None | None | None |
| Amount | $1.0 | $0.095 | $0.095 | $0.09 | $0.09 | $0.09 | $0.09 | $0.375 | $0.375 | $0.375 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: BHC
2026-05-28 20:09:08
Bausch Health's aesthetic business, Solta Medical, announced that its Thermage® brand has received the prestigious AAA Well-Known Trademark Certification from the China Trademark Association. This recognition, achieved by only 217 brands in mainland China, highlights Thermage's strong brand reputation, consumer confidence, and market influence. The certification reinforces Thermage's position as a leader in medical aesthetics and validates its commitment to innovation, quality, and safety in the Chinese market.
2026-05-28 20:09:08
Bausch Health's Solta Medical, through its flagship brand Thermage®, has received the prestigious AAA Well-Known Trademark Certification from the China Trademark Association. This accolade, awarded to only 217 brands in mainland China, recognizes Thermage's strong brand reputation, consumer trust, and market influence. The certification underscores Thermage's leadership in non-invasive aesthetic treatments and commitment to quality and safety in the Chinese market.
2026-05-27 06:39:27
Christian A. Garcia, a director at Bausch Health Companies Inc. (BHC), has been awarded 45,871 common shares in the form of restricted share units (RSUs) with a grant-date value of $250,000. These RSUs, granted on May 22, 2026, are part of his compensation as a non-employee director and will vest immediately before the company's next Annual Meeting of Shareholders. Following this transaction, Garcia directly holds 135,578 Bausch Health common shares.
2026-05-27 06:39:27
Bausch Health Companies Inc. director Frank D. Lee was granted 45,871 Restricted Share Units (RSUs) valued at $250,000 as non-cash compensation. These RSUs, awarded as part of his director compensation, vest before the next Annual Meeting of Shareholders and will be settled in common shares. Following this grant, Lee directly owns 95,210 common shares of Bausch Health.
2026-05-27 00:09:40
Bausch Health Companies Inc. director Amy B. Wechsler was granted 45,871 restricted share units (RSUs) with a grant date value of $250,000. These RSUs will vest immediately before the company’s next Annual Meeting of Shareholders and will be settled in common shares. Following this transaction, Amy Wechsler directly holds 313,585 common shares of Bausch Health.
2026-05-26 23:09:40
Bausch Health Companies Inc. director Robert N. Power was granted 45,871 restricted share units (RSUs) with a grant date value of $250,000. These RSUs will vest immediately before the company's next Annual Meeting of Shareholders and will be settled in common shares. Following this transaction, Mr. Power directly holds 300,594 common shares of Bausch Health.
